tirzepatide for seniors Zepbound: GLP-1s May Raise Frailty, Muscle Loss Risk in Older Adults Tirzepatide for Obesity and Diabetes

According to NICE guideline NG28 , GLP-1 receptor agonists like Ozempic may be considered for adults with type 2 diabetes who have specific criteria, including a BMI of 35 kg/m or higher (adjusted for ethnicity) and specific problems associated with high weight, or a BMI lower than 35 kg/m where insulin would have significant occupational implications or weight loss would benefit other significant obesity-related comorbidities

Our page on All About Liposomes explains why we focus on liposomal delivery , a sophisticated technology designed to protect the nutrient as it travels through your body

Wang et al., 2025

That allowed the rats to lose weight without feeling sick